Grant: Idea to Innovation
Concordia University
$20,000.00
L2M NSERC - Integrated technology for automated cell-by-cell genetic screening
EF 2022-23
Résumé
The genomic information inside a cell (the genome) maps the structural and functional capabilities of a cell. With the advent of more sophisticated gene editing tools (e.g., CRISPR), it is possible to alter the genome by adding, removing or modifying DNA at a particular location with the hopes of obtaining cells with a desired function. By selecting a single cell with a unique genome through rounds of screening, it is possible to select for strains that are capable of producing valuable products (e.g., cannabinoids or biofuels). For more advanced cell characterization, it is necessary to isolate and to grow cells individually, as monoclones. Currently there are very few technologies available to perform the selection and the isolation. The main problems with current methods for generating and isolating the clones are (i) the high costs, (ii) lengthy steps, (iii) lack of control over cell sorting parameters and (iv) the absence of integrated methods for transferring the clones to well-plates, risking the loss of selected clones. In the Shih lab, we have created an invention called "D2-isolate", which is a hand-held device that integrates two microfluidic paradigms: droplet-in-channel and digital microfluidics (DMF). Droplet-in-channel microfluidics can operate in high-throughput ranges to generate droplets containing 0 or 1 cell, but only results in a large mixture of droplets to be analyzed while only ~10% of them contain a cell. DMF systems can address each droplet individually. The integration of the two enables the generation of droplets containing 1 cell with high efficiency (no empty droplet) while controlling/moving each droplet containing a single cell independently. Based on pre-programmed criteria, a cell can automatically be either discarded, or transferred to a 96-well plate for further characterization. As a fully integrated and automated platform, D2-isolate will expedite the workflow for applications related to single-cell generation and analysis. Hence, in this proposal, we aim to evaluate the market for our technology with the goal of expanding the application space related to single-cell technologies and help prepare our efforts towards commercialization.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
576552-2022
Name nom
Shih, Steve SCC
Department département
Electrical and Computer Engineering
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1
Partie
1
Nb partie
1
Application title
L2M NSERC - Integrated technology for automated cell-by-cell genetic screening
Application summary
The genomic information inside a cell (the genome) maps the structural and functional capabilities of a cell. With the advent of more sophisticated gene editing tools (e.g., CRISPR), it is possible to alter the genome by adding, removing or modifying DNA at a particular location with the hopes of obtaining cells with a desired function. By selecting a single cell with a unique genome through rounds of screening, it is possible to select for strains that are capable of producing valuable products (e.g., cannabinoids or biofuels). For more advanced cell characterization, it is necessary to isolate and to grow cells individually, as monoclones. Currently there are very few technologies available to perform the selection and the isolation. The main problems with current methods for generating and isolating the clones are (i) the high costs, (ii) lengthy steps, (iii) lack of control over cell sorting parameters and (iv) the absence of integrated methods for transferring the clones to well-plates, risking the loss of selected clones. In the Shih lab, we have created an invention called "D2-isolate", which is a hand-held device that integrates two microfluidic paradigms: droplet-in-channel and digital microfluidics (DMF). Droplet-in-channel microfluidics can operate in high-throughput ranges to generate droplets containing 0 or 1 cell, but only results in a large mixture of droplets to be analyzed while only ~10% of them contain a cell. DMF systems can address each droplet individually. The integration of the two enables the generation of droplets containing 1 cell with high efficiency (no empty droplet) while controlling/moving each droplet containing a single cell independently. Based on pre-programmed criteria, a cell can automatically be either discarded, or transferred to a 96-well plate for further characterization. As a fully integrated and automated platform, D2-isolate will expedite the workflow for applications related to single-cell generation and analysis. Hence, in this proposal, we aim to evaluate the market for our technology with the goal of expanding the application space related to single-cell technologies and help prepare our efforts towards commercialization.